Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Valeo Pharma Inc T.VPH

Alternate Symbol(s):  T.VPH.DB | VPHIF

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.


TSX:VPH - Post by User

Post by oiljack14on Jul 30, 2020 11:00am
150 Views
Post# 31343608

VPH...CEO...Flavonoid....Canadian market and opportunity

VPH...CEO...Flavonoid....Canadian market and opportunityVPH and Canadian Flavonoid market

https://www.drugbank.ca/categories/DBCAT001281

Here is the current Flavonoid drug market in Canada as of today!

Up to the minute!

Glance at it…it’s a must! The drug space is cutting edge application and research space for many health woes of Canadians and the valuations these drugs once approved for treatment are getting is INSANE! The VPH CEO dropped the hint….will you pick it up before the market “gets it??!” I did. Do as you must


VPH.....ssshhh....you didn't see this word mentioned by the CEO.."Bioflavinoid" Boom! It's worth a tone...one word https://www.healthline.com/health/bioflavonoids#benefits Bioflavinoids can potentially be a real positive treatment for "heart health, cancer prevention, and other issues related to oxidative stress and inflammation, like allergies and asthma." Don't say Oiljack didn't tell you to buy! RMaker my friend....lol....watch me go! No one digs up the research data like me....lol! COVID-19 Fuels Demand for Citrus Bioflavonoid Supplements for Effective Immunoregulation Companies in the citrus bioflavonoids market are capitalizing on value-grab opportunities, due to the ongoing COVID-19 (coronavirus) pandemic, since these health agents help in immunoregulation. Wuhan being the epicenter of the virus reported increasing number of pneumonia cases, which stirred a demand for citrus fruits rich in flavonoids. Thus, citrus bioflavonoid supplements are emerging as a novel candidate to reduce the severity of COVID-19 symptoms. An unprecedented demand for antiviral agents bolstered the credibility of companies in the citrus bioflavonoids market. Health-promoting benefits of flavonoids such as cough relief and regulation of digestive health are helping to increase patient outcomes. Likewise, increased clinical trials validate the importance of hesperidin that acts as an inhibitor to the COVID-19 strain. Hence, manufacturers are increasing their production capabilities to induce hesperidin and naringin in nutraceuticals.
 
<< Previous
Bullboard Posts
Next >>